ECO SCIENCE JOURNALS
M Kadri Altundag
Eco Science Journals
Editor Name: M Kadri Altundag
Country: Turkey
University: Hacettepe University Cancer Institute
Designation: professor of Medical Oncology
Department: Medical Oncology
Email: altundag66@yahoo.com / drkadri@usa.net
Biography:
He has a professor of Medical Oncology at Hacettepe University Cancer Institute. My main interest area is breast cancer. I had been at MD Anderson Cancer Center, Texas, USA between 2004-2006 as visiting scientist and worked there at Breast Medical Oncology Unit. He had breast cancer breast cancer presentations at both international and national conferences. He conducted more than 30 international breast cancer clinical studies. I had my own breast cancer patients since 2006 more than 5000 patients. Fort the last 4-5 years, I saw 60-80 newly diagnosed breast cancer patients every month. He had 629 international publications and 207 international abstracts and 5509 citations
Websites: www.kadrialtundag.com / www.drkadrialtundag.com
Publications:
1. Benekli M, Güllü İH, Savaş C, Kadayıfçı A, Altundağ MK, Tekuzman G, Fırat D. Acute Tumor Lysis Syndrome Following Intrathecal Methotrexate. Leukemia and Lymphoma 1996; 22:361-363.
2. Kars A, Çelik İ, Kansu E, Tekuzman G, Özışık Y, Güler N, Barışta İ, Güllü İ,Yalçın Ş, Altundağ K, Zengin N, Türker A, Hayran M, Baltalı E, Fırat D. Maintenance Therapy with Alpha-Interferon Following First-Line VAD in Multiple Myeloma. European Journal of Haematology 1997;59(2):100-104
3. Öztürk MA, Benekli M, Güler N, Altundağ MK, Barışta İ, Ayhan A. Gastric Adenocarcinoma Metastasis to the Parotid Gland. Journal of Clinical Gastroenterology 1997; 25:698-699.
4. Altundağ MK, Barışta İ. False-positive Urine Melanin Pigment Reaction Caused by Rifampin. The Annals of Pharmacotherapy 1998;32(5):610.
5. Yalçın Ş, Altundağ K, Asıl M, Tekuzman G. Sublingual Piroxicam for Cancer Pain. Medical Oncology 1998;15:137-139.
6. Öztürk A, Benekli M, Altundağ K, Güler N. Squamous cell carcinoma of the skin associates with systemic sclerosis. Dermatological Surgery 1998;24:777-779.
7. Çelik İ, Altundağ K, Erman M, Baltalı E. Cyclophosphamide-associated Carcinoma of the Urinary Bladder in Behçet’s Disease. Nephron 1999; 81: 239.
8. Akata D, Aralasmak A, Ozmen MN, Akhan O, Altundağ K, Güllü İ. US and CT findings of multicentric leiomyosarcomatosis. European Journal of Radiology 1999; 9: 711-714.
9. Güler N, Baltalı E, Altundağ K, Zengin N, Tekuzman G, Özışık Y, Fırat D. Paclitaxel in the salvage treatment of metastatic breast carcinoma. Journal of Balkan Union of Oncology 1999;4:275-281.
10. Barışta İ, Tekuzman G, Yalçın Ş, Güllü İ, Güler N, Özışık Y, Kars A, Çelik İ, Türker A, Altundağ K, Zengin N, Üner A, Baltalı E, Fırat D. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy. Journal of Surgical Oncology 2000;73:12-16.
11. Altundağ MK, Çelik İ. Human Immunodeficiency Virus Negative Kaposi Sarcoma and Lymphoproliferative disorders. Cancer 2000;88:708-709.
12. Altundağ MK, Özışık Y, Yalçın Ş, Akyol F, Üner A. Primary low grade B-cell lymphoma of the dura in an immunocompetent patient. Journal of Experimental and Clinical Cancer Research 2000;19:249-251.
13. Yılmaz M, Farsak B, Altundağ MK, Demircin M, Özkutlu S, Paşaoğlu İ. Isolated cardiac metastasis of osteosarcoma. Journal of Experimental and Clinical Cancer Research 2000;19:395-397
14. Kömürcü Ş, Özet A, Öztürk B, Arpacı F, Altundağ MK, Tezcan Y. Colon cancer during pregnancy: a case report and review of the literature. The Journal of Reproductive Medicine 2001;46:75-78.
15. Baltalı E, Özışık Y, Güler N, Fırat D, Altundağ K. Combination of docetaxel and doxorubicin as first-line chemotherapy in metastatic breast cancer. Tumori 2001;87:18-19.
16. Köklü S, Barışta İ, Altundağ MK, Aksu S, Fırat P. An unusual case of metastatic rectal carcinoma presenting as thyroid nodule. The American Journal of Gastroenterology 2000;95:3689.
17. Altundağ MK, Çelik İ, Özışık Y. Is there a range of time for initiation of adjuvant chemotherapy in patients with malignancy? Annals of Oncology 2000;11:1209.
18. Hasegeli Üner A, Abalı H, Engin H, Akyol A, Ruacan Ş, Tan E, Güllü İ, Altundağ K, Güler N. Myasthenia Gravis and lymphphoblastic lymphoma involving the thymus; a rare association. Leukemia and Lymphoma 2001;42:527-531..
19. Cengiz M, Altundağ MK, Zorlu AF, Güllü İH, Özyar E, Atahan İL. Malignancy in Behçet’s disease: Report of thirteen cases and a review of the literature. Clinical Rheumatology 2001;20:239-244.
20. Abalı H, Altundağ MK, Engin H, Altundağ ÖÖ, Türker A, Üner A, Ruacan Ş. Hypereosinophlia and metastatic anaplastic carcinoma of unknown primary. Medical Oncology 2001;18:285-288.
21. Köklü S, Onat AM, Erol K, Kılıçarslan A, Altundağ MK, Güllü İ. Relapsed prolactinoma 27 years after conventional radiotherapy. American Journal of Clinical Oncology 2002;25:429-430..
22. Kömürcü Ş, Özet A, Altundağ MK, Arpacı F, Öztürk B, Celasun B, Tezcan Y. Vanishing bile duct syndrome occurring after high dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkins disease. Annals of Hematology 2002;81:57-58.
23. Akbay A, Altundağ MK, Özışık Y, Zorlu AF, Palaoğlu S. Reverse seeding of recurrent intraspinal malignant meningioma. Oncology-International Journal of Cancer Research and Treatment 2002;62:386-388.
For More Articles: http://www.drkadrialtundag.com/yayin-listesi
Google Scholar: https://scholar.google.com/citations?user=9JH1UFYAAAAJ&hl=en
ResearchGate: https://www.researchgate.net/profile/Kadri_Altundag
.png)
